Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CASP1 | P29466 | 1/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1025357 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| Cyclohexanone Oxime SCHEMBL15106892 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL3472303 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL3474721 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL3190316 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL1026335 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| Cyclohexanone Oxime SCHEMBL37995 | 1.00 | — | — | |
| Cyclohexanone Oxime SCHEMBL11884936 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL3472281 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL1025081 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2803408-B1 | Method and apparatus for producing oxide of hydrocarbon compound using same | UBE INDUSTRIES (JP) | 2020-11-04 | — | — | EP | disclosed |
| EP-2241552-B1 | PRODUCTION METHOD AND BECKMANN REARRANGEMENT CATALYST FOR PRODUCING A CYCLIC LACTAM COMPOUND | UNIV NAGOYA NAT UNIV CORP (JP) | 2018-11-14 | — | — | EP | disclosed |
| EP-2623199-B1 | OXIDATION CATALYST FOR HYDROCARBON COMPOUND, AND METHOD AND APPARATUS FOR PRODUCING OXIDE OF HYDROCARBON COMPOUND USING SAME | UBE INDUSTRIES (JP) | 2018-11-07 | — | — | EP | disclosed |
| EP-2738161-B1 | METHOD FOR PRODUCING AMIDE COMPOUND | UBE INDUSTRIES (JP) | 2018-04-11 | — | — | EP | disclosed |
| EP-2738162-B1 | METHOD FOR PRODUCING AMIDE COMPOUND | UBE INDUSTRIES (JP) | 2018-01-03 | — | — | EP | disclosed |
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| EP-2548862-B1 | METHOD FOR PRODUCING AMIDE COMPOUND | UBE INDUSTRIES (JP) | 2016-06-08 | — | — | EP | disclosed |
| US-9242931-B2 | Method for producing amide compound | UBE INDUSTRIES, LTD. (JP) | 2016-01-26 | — | — | US | disclosed |
| US-8962826-B2 | Method for producing amide compound | UBE INDUSTRIES, LTD. (JP) | 2015-02-24 | — | — | US | disclosed |
| EP-2241552-A1 | PRODUCTION METHOD AND BECKMANN REARRANGEMENT CATALYST FOR PRODUCING A CYCLIC LACTAM COMPOUND | National University Corporation Nagoya University (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20100029932-A1 | PROCESS FOR PRODUCTION OF AMIDE OR LACTAM | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2116529-A1 | PROCESS FOR PRODUCTION OF AMIDE OR LACTAM | Daicel Chemical Industries, Ltd. (JP) | 2009-11-11 | — | — | EP | disclosed |
| EP-2006283-A9 | PROCESS FOR PRODUCTION OF AMIDES OR LACTAMS | Daicel Chemical Industries, Ltd. (JP) | 2009-07-15 | — | — | EP | disclosed |
| US-20090093628-A1 | Process for Production of Amides or Lactams | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-09 | — | — | US | disclosed |
| EP-2006283-A2 | PROCESS FOR PRODUCTION OF AMIDES OR LACTAMS | Mainichi Intecio. (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-7034184-B2 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-04-25 | — | — | US | disclosed |
| EP-1342714-B1 | Process for producing azine compounds and oxime compounds | DAICEL CHEM (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-10-30 | — | — | US | disclosed |
| EP-1342714-A1 | Process for producing azine compounds and oxime compounds | Daicel Chemical Industries, Ltd. (JP) | 2003-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093628-A1 | Process for Production of Amides or Lactams | AFF1, ADH1C, ADH1A | TSHR 443/4885CASP1 768/4885CHRNA7 2758/4885 |
| US-20030204084-A1 | Process for producing azine compounds and oxime compounds | CBR1, DAO, ALKBH2 | TSHR 198/4885CASP1 2721/4885CHRNA7 1744/4885 |
| US-20100029932-A1 | PROCESS FOR PRODUCTION OF AMIDE OR LACTAM | STS, ASS1, COASY | TSHR 2891/4885CASP1 1377/4885CHRNA7 3304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.